Evidence map›Paper›PMID 40181658›Full record

ArticleHealth expectations : an international journal of public participation in health care and health policy2025

Influencing Factors for the Acceptability of Accessing HIV Pre-exposure Prophylaxis via Community Pharmacies in Wales.

David Gillespie, Adam D N Williams, Richard Ma, Zoe Couzens, Kerenza Hood, Dyfrig A Hughes, Efi Mantzourani, Eleanor Cochrane, Fiona Wood

Abstract read
In one paragraph

Article in Health expectations : an international journal of public participation in health care and health policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David GillespieCentre for Trials Research, School of Medicine, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.ORCID 0000-0002-6934-2928
Adam D N WilliamsCentre for Trials Research, School of Medicine, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.
Richard MaCentre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0000-0001-6877-2785
Zoe CouzensPublic Health Wales NHS Trust, Cardiff, UK.
Kerenza HoodCentre for Trials Research, School of Medicine, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.
Dyfrig A HughesCentre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK.
Efi MantzouraniSchool of Pharmacy, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.
Eleanor CochraneHealth Education and Improvement Wales, Cardiff, UK.
Fiona WoodDivision of Population Medicine and PRIME Centre Wales, School of Medicine, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.ORCID 0000-0001-7397-4074

Funding

This study is funded by the Health and Care Research Wales, Grant/Award Number: Hf-17-1411.
6 · The paper itself

Abstract

introductionHIV prevention methods, such as pre-exposure prophylaxis (PrEP), have been a significant contributing factor to a global decline in HIV transmission. PrEP has been available through the NHS in Wales since 2017. However, access is exclusively via sexual health clinics, and those accessing PrEP do not reflect those being diagnosed with HIV. Widening access beyond sexual health clinics may be one approach to encourage more equitable uptake, and there is growing interest in offering PrEP services in community pharmacies. We, therefore, aimed to explore the acceptability of PrEP services being delivered through community pharmacies among prospective service users.

methodsWe conducted a qualitative interview study of people living in Wales who either (i) currently access, (ii) previously accessed or are (iii) considering accessing PrEP via a sexual health clinic. Participants were recruited via community networks, and interviews were conducted virtually. Our topic guide was informed by Levesque's conceptual framework of access to healthcare, and we used reflexive thematic analysis.

resultsWe interviewed 24 participants and included data from 20 in the analysis. Four themes were generated: experiences of accessing PrEP via sexual health clinics, the prospect of PrEP access via community pharmacies, other community settings in which PrEP may be accessed and concerns around integrated healthcare and healthcare data.

conclusionPrEP access via community pharmacy is likely to be an acceptable option for people. There are uncertainties surrounding what a PrEP service would look like in a community pharmacy setting, and this would need clarifying to prospective users to increase the salience of access. PATIENT AND PUBLIC CONTRIBUTION: A team-based approach was taken for developing the topic guide and agreeing on the codes for this study. This included people with lived experience of accessing PrEP in Wales.

Indexed as

Community Pharmacy ServicesHealth Services AccessibilityHIV InfectionsPatient Acceptance of Health CarePre-Exposure ProphylaxisAdultAnti-HIV AgentsFemaleHumansInterviews as TopicMaleMiddle AgedQualitative ResearchWalesAnti-HIV Agentscommunity pharmacyhealthcare accessHIVpre‐exposure prophylaxisprimary carequalitative research

Identifiers

PMID40181658
PMCPMC11969042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.